SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001199835-20-000242
Filing Date
2020-09-21
Accepted
2020-09-21 13:41:39
Documents
6
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 GENETHERA, INC. 10-K/A, AMENDMENT NO. 1 form-10k.htm 10-K/A 727041
2 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SAR ex31-1.htm EX-31.1 13769
3 CERTIFICATIONS OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECTION ex31-2.htm EX-31.2 13760
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB ex32-1.htm EX-32.1 6507
5 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECTION ex32-2.htm EX-32.2 6558
6 GRAPHIC gt001_v1.jpg GRAPHIC 10303
  Complete submission text file 0001199835-20-000242.txt   783096
Mailing Address 3051 W 105TH AVENUE UNIT 350251 WESTMINSTER CO 80031
Business Address 3051 W 105TH AVENUE UNIT 350251 WESTMINSTER CO 80031 3035069367
GENETHERA INC (Filer) CIK: 0001017110 (see all company filings)

IRS No.: 650622463 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27237 | Film No.: 201186005
SIC: 2836 Biological Products, (No Diagnostic Substances)